Influence of tumor type, disease status, and patient age on self-reported interest regarding participation in cancer clinical trials

Cancer

Volumn 107, Issue 4, 2006, Pages 849-853

  Markman, Maurie ^a   Petersen, Judith ^b   Montgomery, Robert ^b  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b NexCura Inc   (United States)

Author keywords

Cancer related conditions; Clinical trials; Participation; Self declared more "serious conditions"

Indexed keywords

ADULT; AGE; AGED; ARTICLE; CANCER; CANCER PATIENT; CANCER STAGING; CLINICAL TRIAL; DATA BASE; DECISION MAKING; DECISION SUPPORT SYSTEM; ENDOMETRIUM CANCER; FAMILY; FEMALE; HUMAN; INTERNET; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; OVARY CANCER; PATIENT PARTICIPATION; PRIORITY JOURNAL; PROGNOSIS; SELF REPORT;

AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; CLINICAL TRIALS; DECISION MAKING; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; INTERNET; MALE; MIDDLE AGED; NEOPLASM STAGING; NEOPLASMS; PATIENT PARTICIPATION; QUESTIONNAIRES; UNITED STATES;

EID: 33747162454     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.21997     Document Type: Article

References (13)

1. Sateren WB, Trimble EL, Abrams J, et al. How sociodemographics, presence of oncology specialists, and hospital cancer programs affect accrual to cancer treatment trials. J Clin Oncol. 2002;20:2109-2117.
2. Lara PN Jr., Paterniti DA, Chiechi C, et al. Evaluation of factors affecting awareness of and willingness to participate in cancer clinical trials. J Clin Oncol. 2005;23:9282-9289.
3. Hutchins LF, Unger JM, Crowley JJ, et al. Underrepresentation of patients 65 years of age or older in cancer-treatment trials. N Engl J Med. 1999;341:2061-2067.
4. Lewis JH, Kilgore ML, Goldman DP, et al. Participation of patients 65 years of age or older in cancer clinical trials. J Clin Oncol. 2003;21:1383-1389.
5. Talarico L, Chen G, Pazdur R. Enrollment of elderly patients in clinical trials for cancer drug registration: a 7-year experience by the US Food and Drug Administration. J Clin Oncol. 2004;22:4626-4631.
6. Ogle KS, Swanson GM, Woods N, Azzouz F. Cancer and comorbidity: redefining chronic diseases. Cancer. 2000;88:653-663.
7. Yancik R, Ganz PA, Varricchio CG, Conley B. Perspectives on comorbidity and cancer in older patients: approaches to expand the knowledge base. J Clin Oncol. 2001;19:1147-1151.
8. Gosney MA. Clinical assessment of elderly people with cancer. Lancet Oncol. 2005;6:790-797.
9. Markman M, Petersen J, Montgomery R. An examination of characteristics of lung and colon cancer patients participating in a Web-based decision support program. Oncology. 2005;69:311-316.
10. Markman M, Markman MR, Belland A, Petersen J. Profile of ovarian cancer patients seeking information from a proprietary Web-based decision support program. J Womens Health. 2006;15:312-318.
11. Lloyd-Williams F, Mair F, Shiels C, et al. Why are patients in clinical trials of heart failure not like those we see in everyday practice? J Clin Epidemiology. 2003;56:1157-1162.
12. Jemal A, Murray T, Ward E, et al. Cancer statistics, 2005. CA Cancer J Clin. 2005;55:10-30.
13. Comis RL, Miller JD, Aldige CR, Krebs L, Stoval E. Public attitudes toward participation in cancer clinical trials. J Clin Oncol. 2003;21:830-835.